Hydroxyethyl Starch in Sodium Chloride is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by B. Braun Medical Inc.. The primary component is Hydroxyethyl Starch 130/0.4; Sodium Chloride.
| Product ID | 0264-1968_79f3c629-3cc6-4ee7-82e8-6ca0d5ba1f4c |
| NDC | 0264-1968 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Hydroxyethyl Starch in Sodium Chloride |
| Generic Name | Hydroxyethyl Starch In Sodium Chloride |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2015-01-09 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA110013 |
| Labeler Name | B. Braun Medical Inc. |
| Substance Name | HYDROXYETHYL STARCH 130/0.4; SODIUM CHLORIDE |
| Active Ingredient Strength | 6 g/100mL; mg/100mL |
| Pharm Classes | Plasma Volume Expander [EPC],Increased Intravascular Volume [PE],Osmotic Activity [MoA],Starch [CS],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |